Showing 1411-1420 of 2235 results for "".
- FDA Nod for Sientra’s Low Plus Profile Projection Breast Implanthttps://modernaesthetics.com/news/fda-nod-for-sientras-low-plus-profile-projection-breast-implant-1/2473263/The U.S. Food and Drug Administration (FDA) approved Sientra’s Low Plus Profile Projection Breast Implant for breast augmentation in women at least 22 years old, and for women of all ages undergoing breast reconstruction. This product will be commercially available for board-certi
- Cynosure Launches Innovative Tempsure eyeEnvi Handpiece with Improved Function and Greater Comforthttps://modernaesthetics.com/news/cynosure-launches-innovative-tempsure-eyeenvi-handpiece-with-improved-function-and-greater-comfort/2473262/Cynosure's new Tempsure eyeEnvi handpiece features innovative ergonomic pencil grip design and lighter piston tension required to activate the treatment, making it more comfortable for both patient and provider, heating thinner tissue more effectively and comfortably while minimizin
- Ice-slurry Injections May Melt Subcutaneous Fathttps://modernaesthetics.com/news/ice-slurry-injections-may-melt-subcutaneous-fat/2473260/Cryolipolysis with injectable ice-slurry may soon become an efficient, effective and customizable method of body sculpting, according to new research ine Lasers in Surgery and Medicine.
- Crown Laboratories, Inc.'s Announces Leadership Team Growthhttps://modernaesthetics.com/news/crown-laboratories-incs-annouces-leadership-team-growth/2473256/Joe Proctor and Michael McKenna are stepping into new roles at Crown Laboratories. Joe Proctor will transition from General Manager, Aesthetics into the Head of Innovation and Corporate Development for Crown Aesthetics. Mr. Proctor is the founder of Crown
- Bausch Health Suspends Plans for Solta IPOhttps://modernaesthetics.com/news/bausch-health-suspends-plans-for-solta-ipo-1/2473255/Bausch Health Companies Inc. is suspending its plans for the Solta IPO due to challenging market conditions and other factors. Bausch Health stated that the interests of the Company's stakeholders are best served in the near-term by focusing on driving Solta's revenue, profits a
- Calling All Researchers: ProofPilot Is Seeking Research Ideas on Issues Concerning BIPOC Communitieshttps://modernaesthetics.com/news/calling-all-researchers-proofpilot-is-seeking-research-ideas-on-issues-concerning-bipoc-communities/2473253/ProofPilot, a Software as a Service (SaaS) clinical trial research platform, is rolling out its first ever Open Invitation for Research in partnership with the nonprofit organization
- IT Cosmetics Launches Confidence at Work Initiativehttps://modernaesthetics.com/news/it-cosmetics-launches-confidence-at-work-initiative/2473247/IT Cosmetics is launching Confidence at Work, an initiative that aims to bring awareness to the confidence crisis affecting women at work. The Founder of The American Confidence Institute, Alyssa Dver, will serve as the brand's official Confidence Educator.
- Rion Aesthetics Initiates Series Ahttps://modernaesthetics.com/news/rion-aesthetics-initiates-series-a/2473241/With the initiation of Series A funding, Rion Aesthetics presents a unique investment opportunity for aesthetic providers. Rion plans on closing the Series A in the second quarter of 2022. Rion, a regenerati
- Cynosure Receives $60 Million Follow-on Investment from Clayton, Dubilier & Ricehttps://modernaesthetics.com/news/cynosure-recieves-60-million-follow-on-investment-from-clayton-dubilier-rice/2473237/Cynosure, LLC, received $60 million from lead investor Clayton, Dubilier & Rice. The new capital supports the company's plans to continue investing ahead of strong growth to bring innovation to the market and provide comprehensive treatment solutions to its cust
- ISHRS Survey: Surgical Advances; Improvements in Efficiency Driving Need for Fewer Hair Transplant Treatmentshttps://modernaesthetics.com/news/ishrs-survey-surgical-advances-improvements-in-efficiency-driving-need-for-fewer-hair-transplant-treatments/2473235/According to results of a new member survey conducted by the International Society of Hair Restoration Surgery (ISHRS), 68 percent of members reported performing an average of one procedure per patient in 2021 to achieve the desired hair restoration result. This represents a significant improveme